Projects per year
Abstract
Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA4 (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterized protein TTHB144 is a cA4-activated HEPN ribonuclease that also degrades its activator. TTHB144 binds and degrades cA4 at an N-terminal CARF (CRISPR-associated Rossman fold) domain. The two activities can be separated by site-directed mutagenesis. TTHB144 is thus the first example of a self-limiting CRISPR ribonuclease.
Original language | English |
---|---|
Pages (from-to) | 2894-2899 |
Journal | Journal of Molecular Biology |
Volume | 431 |
Issue number | 15 |
Early online date | 6 May 2019 |
DOIs | |
Publication status | Published - 12 Jul 2019 |
Keywords
- CRISPR
- Anti-viral signaling
- Cyclic oligoadenylate
- Ring nuclease
- Thermus thermophilus
Fingerprint
Dive into the research topics of 'A type III CRISPR ancillary ribonuclease degrades its cyclic oligoadenylate activator'. Together they form a unique fingerprint.Projects
- 1 Finished
-
Cyclic oligoadenylate signalling: Cyclic oligoadenylate signalling - a new type of antiviral response
White, M. (PI)
1/01/19 → 31/12/21
Project: Standard